This study aims to evaluate the effectiveness of this facial image-based AI algorithm for screening CAD in high-risk community populations (specifically individuals with diabetes, hypertension, or aged over 65). The main objectives are:
1. To verify if the AI algorithm can accurately distinguish between high-risk and low-risk groups by comparing the actual prevalence of CAD in these groups.
2. To compare the CAD detection rate using this AI screening strategy against the natural detection rate in a real-world cohort.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria:
* Age \>= 18 years.
* Community high-risk population, defined as individuals meeting at least one of the following criteria:
1. Diagnosed with Diabetes Mellitus;
2. Diagnosed with Hypertension;
3. Advanced age (\> 65 years old).
Exclusion Criteria:
* Prior confirmed diagnosis of Coronary Heart Disease (CAD), including clinically diagnosed CAD, history of Coronary Artery Bypass Grafting (CABG), or history of Percutaneous Coronary Intervention (PCI).
* History of diagnosed Heart Failure.
* Significant facial alterations or conditions that may interfere with AI image analysis, such as plastic surgery, severe facial trauma, or heavy makeup.
* Refusal to participate in the study.
Primary outcome measure(s)
Difference in Prevalence of CAD Between AI-Stratified High-Risk and Low-Risk Groups — Up to 6 months Participants in the diagnostic test cohort are stratified into high-risk and low-risk groups using the AI screening strategy. Subsequently, all participants undergo Coronary Computed Tomography Angiography (CCTA). This outcome measures the difference in CAD prevalence between the two groups based on CCTA results.
Trial sites (3)
Facility
City
Region
Status
Zhoukou Chuanhui District Hospital of Traditional Chinese Medicine
Zhoukou
Henan
Recruiting
Zhoukou Specialized Disease Hospital
Zhoukou
Henan
Recruiting
Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Beijing
China
Not Yet Recruiting
More China National Center for Cardiovascular Diseases trials in China
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time on our Cookie Policy page. See also our Privacy Policy.